Kintara Therapeutics falls on reverse stock split plan

TuHURA Biosciences

11/11/2022 14:38

** Shares of cancer therapy developer Kintara Therapeutics
Inc  KTRA.O  fall 18.3% at 9 cents 
    ** Co announces 1-for-50 reverse stock split of its common
stock
    ** KTRA's shares will begin trading on a split-adjusted
basis from Nov. 14
    ** Co says stock split intended to bring co in compliance
with minimum bid price requirement for continued listing on 
Nasdaq 
    ** Up to Thursday's close, stock had fallen ~80% YTD 
 (Reporting by Sriparna Roy)
 ((Sriparna.roy@thomsonreuters.com))